Medpace Holdings, Inc. (MEDP) Free Cash Flow (FCF): $737.82M
The free cash flow (FCF) for Medpace Holdings, Inc. (MEDP) is $737.82M. It is above its 12-month average by 17.66% ($627.07M).
MEDP Free Cash Flow (FCF) Chart
MEDP Average Free Cash Flow (FCF) Chart
MEDP Current vs Average Free Cash Flow (FCF) Chart
MEDP Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$737.82M
FREE CASH FLOW (FCF) AVG TTM
$627.07M
FREE CASH FLOW (FCF) AVG 3Y
$500.51M
FREE CASH FLOW (FCF) AVG 5Y
$410.74M
FREE CASH FLOW (FCF) AVG 10Y
$275.60M
FREE CASH FLOW (FCF) AVG 15Y
N/A
FREE CASH FLOW (FCF) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.66%
CURRENT VS 3Y AVG
+47.41%
CURRENT VS 5Y AVG
+79.63%
CURRENT VS 10Y AVG
+167.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
FCF Analysis
Free Cash Flow (TTM)
$737.82M
FCF Yield
5.57%
Price/FCF
17.9
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Medpace Holdings, Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medpace Holdings, Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Medpace Holdings, Inc. (MEDP)?
- The free cash flow (FCF) for MEDP stock is $737.82M.
- What is the TTM average free cash flow (FCF) for Medpace Holdings, Inc. (MEDP)?
- The TTM average free cash flow (FCF) for MEDP stock is $627.07M.
- What is the 3Y average free cash flow (FCF) for Medpace Holdings, Inc. (MEDP)?
- The 3Y average free cash flow (FCF) for MEDP stock is $500.51M.
- What is the 5Y average free cash flow (FCF) for Medpace Holdings, Inc. (MEDP)?
- The 5Y average free cash flow (FCF) for MEDP stock is $410.74M.
- What is the 10Y average free cash flow (FCF) for Medpace Holdings, Inc. (MEDP)?
- The 10Y average free cash flow (FCF) for MEDP stock is $275.60M.
Medpace Holdings, Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-12-31 | $681.87M |
| 2024-12-31 | $572.27M |
| 2023-12-31 | $396.73M |
| 2022-12-31 | $351.17M |
| 2021-12-31 | $235.06M |
| 2020-12-31 | $227.34M |
| 2019-12-31 | $183.96M |
| 2018-12-31 | $140.56M |
| 2017-12-31 | $85.09M |
| 2016-12-31 | $78.19M |
| 2015-12-31 | $79.41M |
| 2014-12-31 | $69.89M |
| 2013-12-31 | $93.58M |
Related Metrics
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle